Skip to main content

Table 5 Multivariate analysis for breast cancer-specific overall survival

From: Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing

Prognostic factor

P

RR

95% CI

Age

n.s.

-

-

Menopausal status

n.s.

-

-

pT stage

n.s.

-

-

Grade

0.0007

3.89

1.77–8.55

Steroid hormone receptor status

n.s.

-

-

HER2_SCO

n.s.

-

-

HER2_AMP

0.016

3.08

1.24–7.66

HER2_ALG

n.s.

-

-

HER2_COM

n.s.

-

-

  1. CI, confidence interval; n.s., not significant; RR, relative risk.